U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C12H17NO3
Molecular Weight 223.2683
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of CERULENIN

SMILES

[H][C@]1(O[C@]1([H])C(=O)CC\C=C\C\C=C\C)C(N)=O

InChI

InChIKey=GVEZIHKRYBHEFX-NQQPLRFYSA-N
InChI=1S/C12H17NO3/c1-2-3-4-5-6-7-8-9(14)10-11(16-10)12(13)15/h2-3,5-6,10-11H,4,7-8H2,1H3,(H2,13,15)/b3-2+,6-5+/t10-,11-/m1/s1

HIDE SMILES / InChI

Description
Curator's Comment: The description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/21873051 | https://www.ncbi.nlm.nih.gov/pubmed/26005023 | https://www.ncbi.nlm.nih.gov/pubmed/23754252

Cerulenin ((2R,3S)-2,3-epoxy-4-oxo-7,10-trans, trans-dodecadienoylamide) is an antifungal antibiotic isolated from Cephalosporium caerulens, that inhibits eukaryotic lipid and sterol synthesis and blocks lipid modification of proteins. Cerulenin is a potent inhibitor of fatty acid synthase (FAS). It inhibits all known types of FASs: both multifunctional enzyme complexes (Type I) (from yeast, rat liver, mammalian cells, and certain bacteria) and unassociated enzymes (Type II) (from most bacteria, and higher plants). Cerulenin blocks the synthesis of polyketides in a wide variety of organisms, including actinomycetes, fungi, and higher plants. In addition, cerulenin is suggested to inhibit the condensation step in polyketide synthesis as well as fatty acid synthesis. Cerulenin has a wide range of antimicrobial activity, the drug significantly inhibits the growth of yeast-like fungi, such as Candida, Saccharomyces, and Cryptococcus. Cerulenin is commercially available as a biochemical reagent for widespread use in the field of obesity, cancer biology, posttranslational protein modification system, drug discovery research and so on.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
5.8 µM [IC50]
4.0 µM [IC50]
2.5 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Characterization of N-myristoyl transferase inhibitors and their effect on HIV release.
1991 Aug
Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB.
1993 Jun
Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.
1998 Jun
Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis.
1999 Feb
Cerulenin mimics effects of leptin on metabolic rate, food intake, and body weight independent of the melanocortin system, but unlike leptin, cerulenin fails to block neuroendocrine effects of fasting.
2001 Apr
Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism.
2001 Mar 2
Fatty acid synthase inhibition results in a magnetic resonance-detectable drop in phosphocholine.
2008 Aug
Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans.
2009 Jul 17
Patents

Sample Use Guides

SCID mice were treated with Cerulenin 15 and 30 mg/kg every 3 days
Route of Administration: Intraperitoneal
To measure the cytotoxicity of cerulenin against HCT116 and RKO cells, 3x103 cells were plated per well onto 96-well plates. Following overnight culture, cerulenin and oxaliplatin were added at specified concentra¬tions. After 24 h of incubation, cell viability was measured by the mitochondrial activity in reducing 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetra¬zolium monosodium salt (WST-8) to formazan using a Cell Counting kit-8 (Dojindo Laboratories, Kumamoto, Japan). Cells were incubated with a reagent according to the manufac¬turer's instructions. Plates were read at A450 on a spectrometer.
Name Type Language
CERULENIN
MI  
Common Name English
CERULENIN [MI]
Common Name English
2-OXIRANECARBOXAMIDE, 3-((4E,7E)-1-OXO-4,7-NONADIEN-1-YL)-, (2R,3S)-
Systematic Name English
HELICOCERIN
Brand Name English
NSC-116069
Code English
(2R-(2.ALPHA.,3.ALPHA.(4E,7E)))-3-(1-OXONONA-4,7-DIENYL)OXIRANE- 2-CARBOXAMIDE
Systematic Name English
(+)-CERULENIN
Common Name English
OXIRANECARBOXAMIDE, 3-(1-OXO-4,7-NONADIENYL)-, (2R-(2- .ALPHA.,3-.ALPHA.(4E,7E)))-
Systematic Name English
(2R,3S)-2,3-EPOXY-4-OXO-7E,10E-DODECADIENAMIDE
Common Name English
Code System Code Type Description
NSC
116069
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
ECHA (EC/EINECS)
241-424-8
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
DRUG BANK
DB01034
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
DRUG CENTRAL
578
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
FDA UNII
MF286Y830Q
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
WIKIPEDIA
Cerulenin
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
CAS
17397-89-6
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
CHEBI
171741
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
PUBCHEM
5282054
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
EPA CompTox
DTXSID2040995
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY
MERCK INDEX
m3273
Created by admin on Sat Dec 16 09:39:51 GMT 2023 , Edited by admin on Sat Dec 16 09:39:51 GMT 2023
PRIMARY Merck Index